The Approval Process in Action

Source: The Life Sciences Report and Visual Capitalist (5/1/13)

What catalysts in the drug development process move biotech company stocks? The savvy investor must know what steps in the U.S. Food and Drug Administration's approval process can propel a stock up or down. From drug discovery to the much-anticipated PDUFA date, The Life Sciences Report and the Visual Capitalist have collaborated on an infographic that describes both the process and related catalysts.

For news on how catalysts affect specific stocks, read the updated Life Sciences Report Watchlist.

Gold Producer Unlocks Environmental First in Colombia
Source: Streetwise Reports (05/15/2025)

Soma Gold Corp. (TSXV:SOMA; OTC:SMAGF; WKN:A2P4DU) became Colombia's first carbon-neutral mining firm while boosting gold sales and positioning for breakout growth in a bullish market. Read more about this environmental milestone.

Gold Explorer Discovers High-Grade Silica in Japan, Revealing Exceptional Mining Potential
Source: Streetwise Reports (05/15/2025)

Irving Resources Inc. (IRV:CSE; IRVRF:OTCQX) Director and technical adviser Quinton Hennigh talks about the company's projects in Japan on Crescat Capital's Live Market Call. See why one expert says the stock "spells opportunity."

Junior Miner Strikes Visible Gold in Canada
Source: Streetwise Reports (05/15/2025)

Dryden Gold Corp. (DRY:TSXV; DRYGF:OTCQB) intercepted 1,930 g/t gold in Ontario, uncovering a new high-grade zone and boosting momentum in a breakout gold sector environment. Read more about the discovery and whats next for the company.

Interim Data From TID Trial Are Positive
Source: Streetwise Reports (05/15/2025)

Sernova Biotherapeutics Inc.'s (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) regenerative treatment delivered via its Cell Pouch Bio-hybrid Organ is proving to result in insulin independence, among other outcomes. Read what one analyst says are the implications of this clear medical benefit.

Explorer Poised for Breakthrough Partnership on Colossal BC Gold Project
Source: Streetwise Reports (05/15/2025)

Seabridge Gold Inc. (SEA:TSX; SA:NYSE.MKT) announced it has filed its interim financial statements for the first quarter ending March 31 including net earnings of US$10.6 million (US$0.11 per share) compared to a net loss of US$8.2 million (US$0.09 per share) for the same period in 2024. Read why some analysts believe its search for a partner for its massive KSM project could be the company's most important catalyst.